239 related articles for article (PubMed ID: 16734623)
1. Activated gammadelta T cells express the natural cytotoxicity receptor natural killer p 44 and show cytotoxic activity against myeloma cells.
von Lilienfeld-Toal M; Nattermann J; Feldmann G; Sievers E; Frank S; Strehl J; Schmidt-Wolf IG
Clin Exp Immunol; 2006 Jun; 144(3):528-33. PubMed ID: 16734623
[TBL] [Abstract][Full Text] [Related]
2. Natural killer cells in HIV controller patients express an activated effector phenotype and do not up-regulate NKp44 on IL-2 stimulation.
Marras F; Nicco E; Bozzano F; Di Biagio A; Dentone C; Pontali E; Boni S; Setti M; Orofino G; Mantia E; Bartolacci V; Bisio F; Riva A; Biassoni R; Moretta L; De Maria A
Proc Natl Acad Sci U S A; 2013 Jul; 110(29):11970-5. PubMed ID: 23818644
[TBL] [Abstract][Full Text] [Related]
3. Working in "NK Mode": Natural Killer Group 2 Member D and Natural Cytotoxicity Receptors in Stress-Surveillance by γδ T Cells.
Silva-Santos B; Strid J
Front Immunol; 2018; 9():851. PubMed ID: 29740448
[TBL] [Abstract][Full Text] [Related]
4. In vitro analysis of the proliferative capacity and cytotoxic effects of ex vivo induced natural killer cells, cytokine-induced killer cells, and gamma-delta T cells.
Niu C; Jin H; Li M; Xu J; Xu D; Hu J; He H; Li W; Cui J
BMC Immunol; 2015 Oct; 16():61. PubMed ID: 26458364
[TBL] [Abstract][Full Text] [Related]
5. Human NK cytotoxicity against porcine cells is triggered by NKp44 and NKG2D.
Forte P; Lilienfeld BG; Baumann BC; Seebach JD
J Immunol; 2005 Oct; 175(8):5463-70. PubMed ID: 16210654
[TBL] [Abstract][Full Text] [Related]
6. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis.
Vitale M; Bottino C; Sivori S; Sanseverino L; Castriconi R; Marcenaro E; Augugliaro R; Moretta L; Moretta A
J Exp Med; 1998 Jun; 187(12):2065-72. PubMed ID: 9625766
[TBL] [Abstract][Full Text] [Related]
7. Effects of prolactin and cortisol on natural killer (NK) cell surface expression and function of human natural cytotoxicity receptors (NKp46, NKp44 and NKp30).
Mavoungou E; Bouyou-Akotet MK; Kremsner PG
Clin Exp Immunol; 2005 Feb; 139(2):287-96. PubMed ID: 15654827
[TBL] [Abstract][Full Text] [Related]
8. Ex vivo-expanded natural killer cells kill cancer cells more effectively than ex vivo-expanded γδ T cells or αβ T cells.
Deng X; Terunuma H; Terunuma A; Takane T; Nieda M
Int Immunopharmacol; 2014 Oct; 22(2):486-91. PubMed ID: 25131561
[TBL] [Abstract][Full Text] [Related]
9. NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily.
Cantoni C; Bottino C; Vitale M; Pessino A; Augugliaro R; Malaspina A; Parolini S; Moretta L; Moretta A; Biassoni R
J Exp Med; 1999 Mar; 189(5):787-96. PubMed ID: 10049942
[TBL] [Abstract][Full Text] [Related]
10. Direct binding of human NK cell natural cytotoxicity receptor NKp44 to the surfaces of mycobacteria and other bacteria.
Esin S; Batoni G; Counoupas C; Stringaro A; Brancatisano FL; Colone M; Maisetta G; Florio W; Arancia G; Campa M
Infect Immun; 2008 Apr; 76(4):1719-27. PubMed ID: 18212080
[TBL] [Abstract][Full Text] [Related]
11. Molecular analysis of the methylprednisolone-mediated inhibition of NK-cell function: evidence for different susceptibility of IL-2- versus IL-15-activated NK cells.
Chiossone L; Vitale C; Cottalasso F; Moretti S; Azzarone B; Moretta L; Mingari MC
Blood; 2007 May; 109(9):3767-75. PubMed ID: 17234744
[TBL] [Abstract][Full Text] [Related]
12. The proinflammatory cytokines IL-2, IL-15 and IL-21 modulate the repertoire of mature human natural killer cell receptors.
de Rham C; Ferrari-Lacraz S; Jendly S; Schneiter G; Dayer JM; Villard J
Arthritis Res Ther; 2007; 9(6):R125. PubMed ID: 18053164
[TBL] [Abstract][Full Text] [Related]
13. Recognition of viral hemagglutinins by NKp44 but not by NKp30.
Arnon TI; Lev M; Katz G; Chernobrov Y; Porgador A; Mandelboim O
Eur J Immunol; 2001 Sep; 31(9):2680-9. PubMed ID: 11536166
[TBL] [Abstract][Full Text] [Related]
14. The Natural Cytotoxicity Receptor NKp44 (NCR2, CD336) Is Expressed on the Majority of Porcine NK Cells
Mair KH; Crossman AJ; Wagner B; Babasyan S; Noronha L; Boyd P; Zarlenga D; Stadler M; van Dongen KA; Gerner W; Saalmüller A; Lunney JK
Front Immunol; 2022; 13():767530. PubMed ID: 35154097
[TBL] [Abstract][Full Text] [Related]
15. PGE2 inhibits natural killer and gamma delta T cell cytotoxicity triggered by NKR and TCR through a cAMP-mediated PKA type I-dependent signaling.
Martinet L; Jean C; Dietrich G; Fournié JJ; Poupot R
Biochem Pharmacol; 2010 Sep; 80(6):838-45. PubMed ID: 20470757
[TBL] [Abstract][Full Text] [Related]
16. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.
Moretta A; Bottino C; Vitale M; Pende D; Cantoni C; Mingari MC; Biassoni R; Moretta L
Annu Rev Immunol; 2001; 19():197-223. PubMed ID: 11244035
[TBL] [Abstract][Full Text] [Related]
17. Imbalance of NKp44(+)NKp46(-) and NKp44(-)NKp46(+) natural killer cells in the intestinal mucosa of patients with Crohn's disease.
Takayama T; Kamada N; Chinen H; Okamoto S; Kitazume MT; Chang J; Matuzaki Y; Suzuki S; Sugita A; Koganei K; Hisamatsu T; Kanai T; Hibi T
Gastroenterology; 2010 Sep; 139(3):882-92, 892.e1-3. PubMed ID: 20638936
[TBL] [Abstract][Full Text] [Related]
18. Tumor-induced apoptosis of human IL-2-activated NK cells: role of natural cytotoxicity receptors.
Poggi A; Massaro AM; Negrini S; Contini P; Zocchi MR
J Immunol; 2005 Mar; 174(5):2653-60. PubMed ID: 15728472
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of human peripheral blood Vδ1+ T cells expressing the natural cytotoxicity receptor NKp30 for recognition of lymphoid leukemia cells.
Correia DV; Fogli M; Hudspeth K; da Silva MG; Mavilio D; Silva-Santos B
Blood; 2011 Jul; 118(4):992-1001. PubMed ID: 21633088
[TBL] [Abstract][Full Text] [Related]
20. The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells.
El-Sherbiny YM; Meade JL; Holmes TD; McGonagle D; Mackie SL; Morgan AW; Cook G; Feyler S; Richards SJ; Davies FE; Morgan GJ; Cook GP
Cancer Res; 2007 Sep; 67(18):8444-9. PubMed ID: 17875681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
